An artificial intelligence (AI) model developed by Mayo Clinic and Ultromics, Ltd., an AI echocardiography company based in Oxford, England, is highly accurate in screening for cardiac amyloidosis, a ...

Heart disease is the leading cause of adult death worldwide, making cardiovascular disease diagnosis and management a global health priority. An echocardiogram, or cardiac ultrasound, is one of the ...

Complementary MESA analyses validate AI-derived chamber volumetry from non-gated, non-contrast CT for heart failure and ...

In a recent article published in the journal Nature, a team of researchers described a wearable ultrasonic device that allows cardiac function to be assessed directly in real-time, with improved ...

An echocardiogram is the primary diagnostic tool used for tricuspid regurgitation. Also called a diagnostic cardiac ultrasound, this test uses ultrasound technology to produce images of your heart’s ...

Cardiovascular magnetic resonance (CMR) demonstrated diagnostic discordance with transthoracic echocardiography (TTE) in 74% of patients, identifying heart failure with preserved ejection fraction ...

Please provide your email address to receive an email when new articles are posted on . An AI model accurately distinguished cardiac amyloidosis from other phenotypic mimics. The model also showed ...

Approximately 8 out of every 1,000 newborns are affected by a congenital heart defect. CHDs remain the most common type of ...

Training product provides healthcare practitioners, medical schools, and health systems with a simple, effective, and accessible program for mastering cardiac ultrasounds. BORDEAUX, France--(BUSINESS ...

Canon Medical Systems USA, Inc., a leading provider of diagnostic imaging solutions, today announced a reseller relationship with Us2.ai, an AI echocardiography software company, to expand access to ...